Raleigh-based Bryn Pharma brings on new CEO to help launch EpiPen alternative
RALEIGH — Pharmaceutical industry veteran Sandy Loreaux is the new CEO of Raleigh-based Bryn Pharma, the company announced this week.
Previous
Previous
The promise of Web3 goes way beyond cryptocurrencies, says Duke professor
Next
Next